-
1
المؤلفون: Antoni, D., Feuvret, L., Biau, J., Robert, C., Mazeron, J.-J., Noël, G.
المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA)
المصدر: Cancer/Radiothérapie
Cancer/Radiothérapie, 2022, 26 (1-2), pp.116-128. ⟨10.1016/j.canrad.2021.08.006⟩مصطلحات موضوعية: Organs at Risk, Recommandations, MESH: Neoplasm Grading, Recommendations, MESH: Antineoplastic Agents, Alkylating, Radiation Tolerance, MESH: Magnetic Resonance Imaging, MESH: Glioma, Gliome anaplasique, Societies, Medical, MESH: Aged, MESH: Middle Aged, MESH: Organs at Risk, MESH: Radiation Tolerance, Brain Neoplasms, MESH: Glioblastoma, MESH: Clinical Decision-Making, Age Factors, Glioma, Middle Aged, MESH: Radiation Oncology, Magnetic Resonance Imaging, Radiation therapy, Oncology, Diffuse glioma, MESH: Brain Neoplasms, MESH: Biomarkers, Tumor, France, MESH: Karnofsky Performance Status, Gliome diffus, Glioblastome, MESH: Societies, Medical, Clinical Decision-Making, [SDV.CAN]Life Sciences [q-bio]/Cancer, Biomarkers, Tumor, Temozolomide, Humans, Radiology, Nuclear Medicine and imaging, Karnofsky Performance Status, MESH: Temozolomide, Antineoplastic Agents, Alkylating, Radiothérapie, Aged, MESH: Age Factors, French society for radiation oncology, MESH: Humans, Biologie moléculaire, MESH: France, Radiation Oncology, Neoplasm Grading, Glioblastoma, Anaplastic glioma, Biomarkers, Société française de radiothérapie oncologique
-
2
المؤلفون: Hugues Duffau, Andrei Fernandes Joaquim, Joao Paulo Almeida, Lucas Alverne Freitas de Albuquerque, Leonardo José Monteiro de Macêdo Filho
المساهمون: Hospital General de Fortaleza [Fortaleza, Brazil] (HGF), University of Campinas [Campinas] (UNICAMP), Cleveland Clinic, Universidade de Fortaleza Endereço (UNIFOR ), Service de Neurochirurgie [Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-CHU Gui de Chauliac [Montpellier], Institut des Neurosciences de Montpellier - Déficits sensoriels et moteurs (INM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
المصدر: Neurosurgical Review
Neurosurgical Review, Springer Verlag, 2021, 44 (3), pp.1371-1389. ⟨10.1007/s10143-020-01362-8⟩مصطلحات موضوعية: Multivariate statistics, Multivariate analysis, MESH: Neoplasm Grading, Neurosurgical Procedures, 030218 nuclear medicine & medical imaging, MESH: Magnetic Resonance Imaging, MESH: Glioma, 0302 clinical medicine, Molecular signature, Overall survival, Prospective Studies, 10. No inequality, MESH: Treatment Outcome, Brain Neoplasms, General Medicine, Glioma, Magnetic Resonance Imaging, 3. Good health, Systematic review, Treatment Outcome, MESH: Brain Neoplasms, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Neurosurgery, Radiology, MESH: Biomarkers, Tumor, medicine.medical_specialty, Low-grade glioma, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery, Extent of resection, 03 medical and health sciences, medicine, Biomarkers, Tumor, Humans, Radical surgery, Retrospective Studies, MESH: Humans, business.industry, Univariate, MESH: Neurosurgical Procedures, MESH: Retrospective Studies, medicine.disease, MESH: Prospective Studies, Surgery, Neurology (clinical), Neoplasm Grading, business, 030217 neurology & neurosurgery
-
3
المؤلفون: M. Auriche, J.-Y. Blay, Isabelle Ray-Coquard, Julien Mancini, Marie Meurer, Sébastien Salas, Sophie Piperno-Neumann, Anne Floquet, Florence Duffaud, Antoine Italiano, François Bertucci, A Cordoba, T Chevalier, Patricia Pautier, M. Delannes
المساهمون: Service d’Oncologie Médicale [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Département cancer environnement (Centre Léon Bérard - Lyon), Centre Léon Bérard [Lyon], Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER, Department of Medical Oncology, Institut Curie [Paris], Institut Claudius Regaud, Institut Bergonié [Bordeaux], UNICANCER, Biostatistique et technologies de l'information et de la communication (BioSTIC) - [Hôpital de la Timone - APHM] (BiosTIC ), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Gustave Roussy (IGR), Université Lille Nord de France (COMUE)-UNICANCER, Service Biostatistique et Technologies de l’Information et de la Communication [AP-HM Hôpital de la Timone] (BioSTIC), Hôpital de la Timone [CHU - APHM] (TIMONE), Bidaut, Ghislain
المصدر: International Journal of Gynecological Cancer
International Journal of Gynecological Cancer, 2019, 29 (4), pp.691-698. ⟨10.1136/ijgc-2018-000064⟩
International Journal of Gynecological Cancer, Lippincott, Williams & Wilkins, 2019, 29 (4), pp.691-698. ⟨10.1136/ijgc-2018-000064⟩مصطلحات موضوعية: [SDV]Life Sciences [q-bio], medicine.medical_treatment, MESH: Neoplasm Grading, MESH: Aged, 80 and over, 0302 clinical medicine, MESH: Treatment Outcome, MESH: Aged, Aged, 80 and over, Undifferentiated Uterine Sarcoma, MESH: Middle Aged, 030219 obstetrics & reproductive medicine, Standard treatment, Obstetrics and Gynecology, Middle Aged, 3. Good health, [SDV] Life Sciences [q-bio], Treatment Outcome, Oncology, MESH: Chemotherapy, Adjuvant, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, MESH: Endometrial Neoplasms, Sarcoma, Adjuvant, Adult, medicine.medical_specialty, MESH: Radiotherapy, Adjuvant, Ovariectomy, Sarcoma, Endometrial Stromal, Brachytherapy, MESH: Ovariectomy, MESH: Sarcoma, Endometrial Stromal, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Hysterectomy, 03 medical and health sciences, MESH: Hysterectomy, medicine, Humans, [SDV.BC] Life Sciences [q-bio]/Cellular Biology, Aged, Retrospective Studies, Chemotherapy, MESH: Humans, Endometrial stromal sarcoma, business.industry, MESH: Adult, MESH: Retrospective Studies, medicine.disease, Endometrial Neoplasms, Surgery, Radiotherapy, Adjuvant, Neoplasm Grading, business, MESH: Female
-
4
المؤلفون: Felice Giangaspero, Chris Jones, Christophe Deroulers, Dominique Figarella-Branger, Marie-Cécile Le Deley, Thomas S. Jacques, Gwénaël Le Teuff, Tim Jaspan, Torsten Pietsch, J. Grill, Pascale Varlet, Felipe Andreiuolo, Christine Haberler
المساهمون: Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Laboratoire d'Anatomie Pathologique-Neuropathologique [AP-HM Hôpital La Timone], Hôpital de la Timone [CHU - APHM] (TIMONE), Imagerie et Modélisation en Neurobiologie et Cancérologie (IMNC (UMR_8165)), Université Paris-Sud - Paris 11 (UP11)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS)
المصدر: Neuro-Oncology
Neuro-Oncology, 2020, 22 (1), pp.116-127. ⟨10.1093/neuonc/noz142⟩
Neuro-Oncology, 2019, 22 (1), pp.116-127. ⟨10.1093/neuonc/noz142⟩
Neuro-Oncology, Oxford University Press (OUP), 2020, 22 (1), pp.116-127. ⟨10.1093/neuonc/noz142⟩مصطلحات موضوعية: Male, Oncology, Cancer Research, [SDV]Life Sciences [q-bio], Datasets as Topic, MESH: Neoplasm Grading, Central Pathology Review, MESH: World Health Organization, MESH: Glioma, 0302 clinical medicine, MESH: Child, Multicenter Studies as Topic, MESH: Datasets as Topic, Child, Randomized Controlled Trials as Topic, MESH: Chemoradiotherapy, [PHYS]Physics [physics], biology, Brain Neoplasms, Chemoradiotherapy, Glioma, Prognosis, 3. Good health, Bevacizumab, Glioma grading, Child, Preschool, 030220 oncology & carcinogenesis, Ki-67, MESH: Brain Neoplasms, Female, MESH: Clinical Trials, Phase II as Topic, high-grade glioma, medicine.medical_specialty, Adolescent, Antineoplastic Agents, World Health Organization, World health, MESH: Prognosis, 03 medical and health sciences, Clinical Trials, Phase II as Topic, MESH: Bevacizumab, Internal medicine, grading criteria, pediatric, Temozolomide, medicine, Humans, Grading (tumors), MESH: Temozolomide, High-Grade Glioma, MESH: Adolescent, MESH: Humans, business.industry, MESH: Child, Preschool, Who grade, medicine.disease, MESH: Male, MESH: Randomized Controlled Trials as Topic, biology.protein, MESH: Multicenter Studies as Topic, MESH: Antineoplastic Agents, Neurology (clinical), Neoplasm Grading, business, Pediatric Neuro-Oncology, MESH: Female, 030217 neurology & neurosurgery
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c30c372eca73b2c55e143342be6cccbc
https://hal.science/hal-03141590 -
5
المؤلفون: Klaus Schlaefer, Martie van Tongeren, Daniel Krewski, Jack Siemiatycki, Maria Blettner, Geza Benke, Jordi Figuerola, Sarah Fleming, Martine Hours, Elisabeth Cardis, Michelle C. Turner, Lesley Richardson, Laurel Kincl, Marie-Élise Parent, Siegal Sadetzki, Brigitte Schlehofer, David McLean
المساهمون: Monash University [Clayton], Universitat Pompeu Fabra [Barcelona] (UPF), CIBER de Epidemiología y Salud Pública (CIBERESP), University of Ottawa [Ottawa], University of Leeds, Oregon State University (OSU), Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM), Johannes Gutenberg - Universität Mainz = Johannes Gutenberg University (JGU), Institut Armand Frappier (INRS-IAF), Institut National de la Recherche Scientifique [Québec] (INRS)-Réseau International des Instituts Pasteur (RIIP), Sackler Faculty of Medicine, Tel Aviv University (TAU), Chaim Sheba Medical Center, German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), Institute of Occupational Medicine [Edinburgh] (IOM), University of Manchester [Manchester], Instituto de Salud Global - Institute For Global Health [Barcelona] (ISGlobal), This work was funded by the National Institutes for Health (NIH) Grant No. 1R01CA124759-01. Coding of the French occupational data was in part funded by AFSSET (Convention No. ST-2005-004). The INTERPHONE study was supported by funding from the European Fifth Framework Program, ‘Quality of Life and Management of Living Resources’ (contract 100 QLK4-CT-1999901563) and the International Union against Cancer (UICC). The UICC received funds for this purpose from the Mobile Manufacturers’ Forum and GSM Association. In Australia, funding was received from the Australian National Health and Medical Research 5 Council (EME Grant 219129) with funds originally derived from mobile phone service licence fees, a University of Sydney Medical Foundation Program, the Cancer Council NSW and The Cancer Council Victoria. In Canada, funding was received from the Canadian Institutes of Health Research (project MOP-42525), the Canada Research Chair programme, the Guzzo-Cancer Research Society Chair in Environment and Cancer, the Fonds de la recherche en sante du Quebec, the Canadian Institutes of Health Research (CIHR), the latter including partial support from the Canadian Wireless Telecommunications Association, and the NSERC/SSHRC/McLaughlin Chair in Population Health Risk Assessment at the University of Ottawa. In France, funding was received by l’Association pour la Recherche sur le Cancer (ARC) (Contrat N85142) and three network operators (Orange, SFR, Bouygues Telecom). In Germany, funding was received from the German Mobile Phone Research Program (Deutsches Mobilfunkforschungsprogramm) of the German Federal Ministry for the Environment, Nuclear 45 Safety, and Nature Protection, the Ministry for the Environment and Traffic of the state of Baden-Wurttemberg, the Ministry for the Environment of the state of North Rhine-Westphalia, and the MAIFOR Program (Mainzer Forschungsforderungsprogramm) of the University of Mainz. In New Zealand, funding was provided by the Health Research Council, Hawkes Bay Medical Research Foundation, the Wellington Medical Research Foundation, the Waikato Medical Research Foundation and the Cancer Society of New Zealand. Additional funding for the UK study was received from the Mobile Telecommunications, Health and Research (MTHR) program, funding from the Health and Safety Executive, the Department of Health, the UK Network Operators (O2, Orange, T-Mobile, Vodafone, ‘3’) and the Scottish Executive. Michelle C Turner was funded by a Government of Canada Banting Postdoctoral Fellowship., European Project: 1999901563,QLK4-CT, Johannes Gutenberg - Universität Mainz (JGU), Réseau International des Instituts Pasteur (RIIP)-Institut National de la Recherche Scientifique [Québec] (INRS), Tel Aviv University [Tel Aviv]
المصدر: British Journal of Cancer
British Journal of Cancer, 2017, 117 (8), pp.1246-1254. ⟨10.1038/bjc.2017.285⟩
Benke, G, Turner, M C, Fleming, S, Figuerola, J, Kincl, L, Richardson, L, Blettner, M, Hours, M, Krewski, D, McLean, D, Parent, M-E, Sadetzki, S, Schlaefer, K, Schlehofer, B, Siemiatycki, J, van Tongeren, M & Cardis, E 2017, ' Occupational solvent exposure and risk of glioma in the INTEROCC study ', BJC, vol. 117, pp. 1246-1254 . https://doi.org/10.1038/bjc.2017.285
British Journal of Cancer, Cancer Research UK, 2017, 117 (8), pp.1246-1254. ⟨10.1038/bjc.2017.285⟩مصطلحات موضوعية: Male, Oncology, MESH: United Kingdom, Cancer Research, Epidemiology, [SDV]Life Sciences [q-bio], MESH: Neoplasm Grading, MESH: Solvents, MESH: Occupational Exposure, MESH: Glioma, Tumor grade, chemistry.chemical_compound, 0302 clinical medicine, Risk Factors, MESH: New Zealand, MESH: Risk Factors, Germany, Odds Ratio, Israel, Young adult, MESH: Aged, Occupation, MESH: Middle Aged, Brain Neoplasms, Age Factors, MESH: Israel, Glioma, Middle Aged, 030210 environmental & occupational health, MESH: Case-Control Studies, 3. Good health, MESH: Young Adult, 030220 oncology & carcinogenesis, Solvent, MESH: Brain Neoplasms, Female, France, Adult, Canada, medicine.medical_specialty, Adolescent, Case–control study, Job-exposure matrix, MESH: Australia, Young Adult, 03 medical and health sciences, Sex Factors, MESH: Sex Factors, MESH: Canada, Occupational Exposure, Internal medicine, medicine, Journal Article, Humans, MESH: Germany, Aged, MESH: Adolescent, MESH: Age Factors, MESH: Humans, business.industry, Australia, Case-control study, MESH: Adult, Odds ratio, medicine.disease, United Kingdom, Confidence interval, MESH: Male, MESH: Odds Ratio, MESH: France, chemistry, Case-Control Studies, Solvents, Neoplasm Grading, Solvent exposure, business, MESH: Female, New Zealand
وصف الملف: application/pdf
-
6
المؤلفون: Rocio Lopez, Pierre Hainaut, Iris Suarez M, Germán Osorio, Pascal Pineau, Diego Uribe, Sergio Hoyos, Juan Camilo Pérez, Maria-C Navas, Carlos Mario Jaramillo
المساهمون: Grupo de Gastrohepatologia [Medellin, Colombia], Universidad de Antioquia = University of Antioquia [Medellín, Colombia], Departamento de Patologia [Medellin, Colombia], Facultad de Psicología, Valencia, Hospital Pablo Tobón Uribe [Medellín, Colombie], Fundacion Santa Fe de Bogota [Colombia], International Prevention Research Institute (IPRI), Organisation Nucléaire et Oncogenèse / Nuclear Organization and Oncogenesis, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), This study was funded by Departamento Nacional de Ciencia, Innovación y Tecnologia Colciencias (Grant 111540820471) and Proyecto de Sostenibilidad, Vicerrectoría de Investigación, Universidad de Antioquia., We thank Dr. Anne Lise Haenni from the Institut Jacques Monod for critical reading of the manuscript and Dr. Andres Arias from Universidad de Antioquia for discussion of the results. We also thank Ghyslaine Martel from International Agency for Research on Cancer (IARC) and Beatriz Vieco from Departamento de Patología, Universidad de Antioquia, for technical assistance., Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: Annals of hepatology : official journal of the Mexican Association of Hepatology
Annals of hepatology : official journal of the Mexican Association of Hepatology, Elsevier, 2015, 14 (1), pp.64-74. ⟨10.1016/S1665-2681(19)30802-6⟩
Annals of Hepatology, Vol 14, Iss 1, Pp 64-74 (2015)
Annals of hepatology : official journal of the Mexican Association of Hepatology, 2015, 14 (1), pp.64-74. ⟨10.1016/S1665-2681(19)30802-6⟩مصطلحات موضوعية: Pathology, MESH: Wnt Signaling Pathway / genetics, Specialties of internal medicine, MESH: Neoplasm Grading, MESH: Colombia, medicine.disease_cause, Exon, MESH: Aged, 80 and over, MESH: Liver Neoplasms / genetics, CTNNB1, HCC, MESH: Cohort Studies, HBV infection, MESH: Aged, Mutation, MESH: Middle Aged, Subcellular localization, MESH: Hepatitis B, Chronic / complications, Wnt signaling pathway, MESH: Carcinoma, Hepatocellular / pathology, General Medicine, MESH: beta Catenin / metabolism, Hepatitis B, 3. Good health, RC581-951, Hepatocellular carcinoma, Immunohistochemistry, MESH: Liver Neoplasms / etiology, medicine.medical_specialty, MESH: Carcinoma, Hepatocellular / etiology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Biology, [SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], medicine, Carcinoma, neoplasms, Gene, MESH: Age Factors, MESH: beta Catenin / genetics, MESH: Liver Neoplasms / pathology, MESH: Humans, Hepatology, MESH: Carcinoma, Hepatocellular / genetics, MESH: Retrospective Studies, MESH: Immunohistochemistry, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, β-catenin, medicine.disease, MESH: Male, digestive system diseases, MESH: Mutation, Cancer research, MESH: Exons, MESH: Female
-
7
المؤلفون: Andrea Gombos, Stefan Michiels, Fabienne Lebrun, Dimitrios Zardavas, Christos Sotiriou, Ahmad Awada, Lieveke Ameye, Jean-Marie Nogaret, Michail Ignatiadis, Evandro de Azambuja, Marion Maetens, Denis Larsimont, Celine Wilke, Marianne Paesmans, Véronique D'Hondt, Martine Piccart, Lissandra Dal Lago, Fanny Bustin, Marie-Catherine Vanderbeeken, Marc Lemort, Isabelle Veys
المساهمون: Herrada, Anthony, Clinique d'Oncologie Médicale [Brussels, Belgium], Université libre de Bruxelles (ULB)-Institut Jules Bordet [Bruxelles], Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB)-Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB), Laboratoire de recherche translationnelle sur le cancer du sein [Brussels, Belgium], Breast International Group [Brussels, Belgium] (BIG aisbl), Département de Radiologie [Brussels, Belgium] (ULB), Medigene AG [Planegg, Germany], Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Méthodologie et épidémiologie clinique en oncologie moléculaire (U1018 (Équipe 2)), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Gustave Roussy (IGR), IJB was the sponsor of this study and Medigene AG provided the EndoTAG-1 and an educational grant. Medigene AG provided support in the form of salaries for author CW., Institut Jules Bordet [Bruxelles], Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB)
المصدر: PLoS ONE
PLoS ONE, 2016, 11 (7), pp.e0154009. ⟨10.1371/journal.pone.0154009⟩
PloS one, 11 (7
PLoS ONE, Vol 11, Iss 7, p e0154009 (2016)
PLoS ONE, Public Library of Science, 2016, 11 (7), pp.e0154009. ⟨10.1371/journal.pone.0154009⟩مصطلحات موضوعية: medicine.medical_treatment, Psychologie appliquée, Diagnostic Radiology, 0302 clinical medicine, Animal Cells, Antineoplastic Combined Chemotherapy Protocols, Medicine, lcsh:Science, MESH: Treatment Outcome, MESH: Middle Aged, Induction Chemotherapy, Sciences bio-médicales et agricoles, MESH: Induction Chemotherapy, 3. Good health, MESH: Antineoplastic Combined Chemotherapy Protocols, Oncology, Paclitaxel, Fluorouracil, 030220 oncology & carcinogenesis, MESH: Biomarkers, Tumor, Cellular Types, Biologie, Clinical Oncology, medicine.medical_specialty, Imaging Techniques, Immune Cells, Immunology, Urology, Surgical and Invasive Medical Procedures, MESH: Epirubicin, 03 medical and health sciences, Breast cancer, Drug Therapy, [SDV.CAN] Life Sciences [q-bio]/Cancer, Humans, Cyclophosphamide, Blood Cells, MESH: Humans, lcsh:R, Biology and Life Sciences, MESH: Cyclophosphamide, MESH: Adult, medicine.disease, 030104 developmental biology, chemistry, lcsh:Q, Neoplasm Grading, Clinical Medicine, MESH: Female, MESH: Fluorouracil, 0301 basic medicine, MESH: Combined Modality Therapy, Receptor, ErbB-2, Cancer Treatment, lcsh:Medicine, MESH: Neoplasm Grading, MESH: Magnetic Resonance Imaging, White Blood Cells, chemistry.chemical_compound, Breast Tumors, Medicine and Health Sciences, Multidisciplinary, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Pharmaceutics, Radiology and Imaging, MESH: Neoplasm Staging, Middle Aged, Combined Modality Therapy, Magnetic Resonance Imaging, MESH: Receptor, ErbB-2, Treatment Outcome, Surgical Oncology, Female, Research Article, medicine.drug, Epirubicin, Adult, Neutropenia, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, Research and Analysis Methods, Diagnostic Medicine, Breast Cancer, Biomarkers, Tumor, Hypersensitivity, Chemotherapy, MESH: Paclitaxel, Neoplasm Staging, business.industry, Cancers and Neoplasms, Induction chemotherapy, Cell Biology, Surgery, Clinical Immunology, business, MESH: Breast Neoplasms, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
وصف الملف: application/pdf; 1 full-text file(s): application/pdf
-
8
المؤلفون: Annie Laquerrière, Bernard George, Jean-Luc Prétet, Loïc Feuvret, Schahrazed Bouazza, François Labrousse, Homa Adle-Biassette, Eleonora Aronica, Séverine Valmary-Degano, Sébastien Froelich, Fabrice Projetti, Henri Salle, Marc Polivka, Marc Pocard, Marie-Hélène Aubriot-Lorton, Arnault Tauziède-Espariat, Loic Chaigneau, Franck Monnien, Philippe Herman, Nicolas Isambert, Damien Bresson
المساهمون: Cellular and Computational Neuroscience (SILS, FNWI), ANS - Cellular & Molecular Mechanisms, Pathology, APH - Amsterdam Public Health, Centre Hospitalier Sainte Anne [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Lariboisière-Fernand-Widal [APHP], Hôpital Lariboisière, Université Paris Diderot - Paris 7 (UPD7)-Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université de Limoges (UNILIM), Genome Analysis, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Service d'Anatomie Pathologique [CHU Limoges], CHU Limoges, Laboratoire de Neurobiologie des Réseaux Sensorimoteurs (LNRS), Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5), Service de Neurochirurgie [CHU Limoges]
المصدر: Journal of Neuropathology and Experimental Neurology, 75(2), 111-120. Lippincott Williams & Wilkins
Journal of neuropathology and experimental neurology, 75(2), 111-120. Lippincott Williams and Wilkins
Journal of Neuropathology and Experimental Neurology
Journal of Neuropathology and Experimental Neurology, Lippincott, Williams & Wilkins, 2016, 75 (2), pp.111-120. ⟨10.1093/jnen/nlv010⟩مصطلحات موضوعية: Oncology, Male, Pathology, Neoplasm, Residual, MESH: Neoplasm Grading, Apoptosis, medicine.disease_cause, Cohort Studies, chemistry.chemical_compound, 0302 clinical medicine, MESH: Child, Epidermal growth factor receptor, Child, MESH: Cohort Studies, MESH: Aged, Univariate analysis, MESH: Middle Aged, biology, MESH: Infant, Newborn, General Medicine, Middle Aged, Prognosis, MESH: Infant, Immunohistochemistry, 3. Good health, Vascular endothelial growth factor, Neurology, MESH: Young Adult, MESH: Survival Analysis, 030220 oncology & carcinogenesis, Child, Preschool, Female, MESH: Biomarkers, Tumor, KRAS, Protons, Adult, medicine.medical_specialty, Adolescent, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Prognosis, Disease-Free Survival, Pathology and Forensic Medicine, 03 medical and health sciences, Cellular and Molecular Neuroscience, Necrosis, Young Adult, Internal medicine, medicine, Biomarkers, Tumor, Chordoma, Humans, neoplasms, MESH: Neoplasm, Residual, PI3K/AKT/mTOR pathway, Survival analysis, Aged, Retrospective Studies, MESH: Adolescent, MESH: Necrosis, MESH: Humans, business.industry, MESH: Apoptosis, MESH: Child, Preschool, Infant, Newborn, MESH: Chordoma, Infant, MESH: Adult, MESH: Retrospective Studies, MESH: Immunohistochemistry, Retrospective cohort study, medicine.disease, Survival Analysis, MESH: Male, chemistry, MESH: Disease-Free Survival, biology.protein, MESH: Protons, Neurology (clinical), Neoplasm Grading, business, MESH: Female, 030217 neurology & neurosurgery
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cc84c5470197e316ef52a52a1d34dc1
https://dare.uva.nl/personal/pure/en/publications/prognostic-and-therapeutic-markers-in-chordomas-a-study-of-287-tumors(eb36926b-f70b-44d6-b4b6-0963120328e5).html -
9
المؤلفون: Andrew J. Hall, Ebrima Bah, Christopher P. Wild, Yusuke Shimakawa
المساهمون: Department of Infectious Disease Epidemiology [London] (IDE), Faculty of Epidemiology and Population Health [London], London School of Hygiene and Tropical Medicine (LSHTM)-London School of Hygiene and Tropical Medicine (LSHTM), Gambia Hepatitis Intervention Study, Medical Research Council Unit The Gambia (MRC)-International Agency for Research on Cancer (IARC), Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), They acknowledge the Gambian Government, Medical Research Council (MRC) and IARC for funding the GNCR, The authors are grateful to colleagues at the Gambia National Cancer Registry (GNCR) for help with this study: Yusupha Bah, Lamin Giana, Ebrima Bojang, Mariato Rahman and Yusupha Colley. They also thank Elizabeth Turner for technical advice on the capture–recapture methods, and Louise Pealing and Freddie Bray for improving the manuscript.
المصدر: International Journal of Cancer
International Journal of Cancer, Wiley, 2013, 132 (3), pp.658-665. ⟨10.1002/ijc.27646⟩مصطلحات موضوعية: Male, Rural Population, validity, Cancer Research, MESH: Gambia / epidemiology, MESH: Neoplasms / epidemiology, Population, MESH: Neoplasm Grading, Health Services Accessibility, MESH: Rural Population, Neoplasms, parasitic diseases, Health care, cancer registry, Humans, Medicine, MESH: Data Collection, Registries, quality control, education, Young male, MESH: Health Services Accessibility, education.field_of_study, MESH: Humans, Data collection, business.industry, Data Collection, International standard, Cancer, MESH: Registries / statistics & numerical data, medicine.disease, MESH: Male, Cancer registry, Oncology, completeness, MESH: Information Systems, Data quality, Africa, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Female, Gambia, MESH: Registries / standards, Neoplasm Grading, business, MESH: Female, Information Systems, Demography
-
10
المؤلفون: Suarez, Iris, Uribe, Diego, Jaramillo, Carlos, Osorio, German, Pérez, Juan, Lopez, Rocio, Hoyos, Sergio, Hainaut, Pierre, Pineau, Pascal, Navas, Maria-C
المساهمون: Grupo de Gastrohepatologia [Medellin, Colombia], Universidad de Antioquia = University of Antioquia [Medellín, Colombia], Departamento de Patologia [Medellin, Colombia], Facultad de Psicología, Valencia, Hospital Pablo Tobón Uribe [Medellín, Colombie], Fundacion Santa Fe de Bogota [Colombia], International Prevention Research Institute (IPRI), Organisation Nucléaire et Oncogenèse / Nuclear Organization and Oncogenesis, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), This study was funded by Departamento Nacional de Ciencia, Innovación y Tecnologia Colciencias (Grant 111540820471) and Proyecto de Sostenibilidad, Vicerrectoría de Investigación, Universidad de Antioquia., We thank Dr. Anne Lise Haenni from the Institut Jacques Monod for critical reading of the manuscript and Dr. Andres Arias from Universidad de Antioquia for discussion of the results. We also thank Ghyslaine Martel from International Agency for Research on Cancer (IARC) and Beatriz Vieco from Departamento de Patología, Universidad de Antioquia, for technical assistance., Pineau, Pascal
المصدر: Annals of hepatology : official journal of the Mexican Association of Hepatology
Annals of hepatology : official journal of the Mexican Association of Hepatology, 2015, 14 (1), pp.64-74. ⟨10.1016/S1665-2681(19)30802-6⟩مصطلحات موضوعية: MESH: Wnt Signaling Pathway / genetics, MESH: Neoplasm Grading, MESH: Carcinoma, Hepatocellular / etiology, MESH: Colombia, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Aged, 80 and over, [SDV.CAN] Life Sciences [q-bio]/Cancer, [SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], MESH: Liver Neoplasms / genetics, CTNNB1, HCC, neoplasms, MESH: Cohort Studies, HBV infection, MESH: Age Factors, MESH: Aged, MESH: beta Catenin / genetics, MESH: Liver Neoplasms / pathology, MESH: Humans, MESH: Middle Aged, Subcellular localization, MESH: Hepatitis B, Chronic / complications, MESH: Carcinoma, Hepatocellular / genetics, MESH: Carcinoma, Hepatocellular / pathology, MESH: Retrospective Studies, MESH: Immunohistochemistry, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, β-catenin, MESH: beta Catenin / metabolism, digestive system diseases, MESH: Male, [SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, Mutation, MESH: Mutation, [SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], MESH: Liver Neoplasms / etiology, MESH: Exons, MESH: Female
وصف الملف: application/pdf
Find this article in full text from Springer Verlag. 
Full Text via ClinicalKey